pyrroles has been researched along with Carcinoma, Medullary in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casado Herráez, A; Currás Freixes, M; Díaz Pérez, JÁ; Ochagavía Cámara, S | 1 |
| Borrello, MG; Cassinelli, G; Castiglioni, V; Cominetti, D; Dal Bo, L; Favini, E; Folini, M; Lanzi, C; Lopergolo, A; Nicolini, V; Perego, P; Scanziani, E; Tortoreto, M; Zaffaroni, N | 1 |
| Hershman, JM; Moatamed, F; Naeim, F; Sugawara, M; Tomoda, C | 1 |
| Borges, A; Bugalho, MJ; Domingues, R | 1 |
| Moretti, S; Puxeddu, E; Romagnoli, S; Voce, P | 1 |
| Asselineau, J; Catargi, B; de la Fouchardière, C; Delord, JP; Do Cao, C; Klein, M; Niccoli, P; Ravaud, A; Rodien, P | 1 |
| Fagin, JA; Pfister, DG; Tuttle, RM | 1 |
| Gkountouvas, A; Kaldrimidis, P; Kostoglou-Athanassiou, I; Repousis, P; Veniou, E; Ziras, N | 1 |
| Cleary, JM; Lynch, TP; Nikiforov, YE; Palmer, EL; Randolph, GW; Sadow, PM; Wirth, LJ | 1 |
| Bauman, JE; Capell, PT; Carr, LL; Eaton, KD; Goulart, BH; Kell, EM; Mankoff, DA; Martins, RG | 1 |
| Ameur, N; Bidart, JM; Broutin, S; Caillou, B; Dupuy, C; Lacroix, L; Oumata, N; Petit, B; Robert, T; Schlumberger, M; Talbot, M | 1 |
| Kelleher, FC; McDermott, R | 1 |
1 review(s) available for pyrroles and Carcinoma, Medullary
| Article | Year |
|---|---|
Targeted molecular therapies in thyroid carcinoma.
Topics: Antineoplastic Agents; Axitinib; Benzenesulfonates; Carcinoma, Medullary; Carcinoma, Papillary; Humans; Imidazoles; Indazoles; Indoles; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thyroid Neoplasms | 2009 |
2 trial(s) available for pyrroles and Carcinoma, Medullary
| Article | Year |
|---|---|
Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSU.
Topics: Antineoplastic Agents; Carcinoma, Medullary; Humans; Indoles; Pyrroles; Sunitinib; Thyroid Neoplasms | 2010 |
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Medullary; Cell Differentiation; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Indoles; Iodine; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Pyrroles; Sunitinib; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Failure | 2010 |
9 other study(ies) available for pyrroles and Carcinoma, Medullary
| Article | Year |
|---|---|
Three cases of sporadic medullary thyroid carcinoma in progression treated with sunitinib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Medullary; Combined Modality Therapy; Hand-Foot Syndrome; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Neck Dissection; Neoplasms, Second Primary; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Thrombocytopenia; Thyroid Neoplasms; Thyroidectomy | 2014 |
Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Medullary; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Humans; Indoles; Mice; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Thyroid Neoplasms | 2014 |
Indomethacin inhibits cell growth of medullary thyroid carcinoma by reducing cell cycle progression into S phase.
Topics: Antineoplastic Agents; Apoptosis; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Cell Cycle; Cell Line; Cell Proliferation; Cyclooxygenase Inhibitors; Dinoprostone; Gene Expression; Humans; Indoles; Indomethacin; Phosphorylation; Pyrroles; Retinoblastoma Protein; S Phase; Sunitinib; Thyroid Neoplasms | 2008 |
A case of advanced medullary thyroid carcinoma successfully treated with sunitinib.
Topics: Antineoplastic Agents; Carcinoma, Medullary; Humans; Indoles; Male; Middle Aged; Mutation; Prognosis; Proto-Oncogene Proteins c-ret; Pyrroles; Sunitinib; Thyroid Neoplasms; Treatment Outcome | 2009 |
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Carcinoma, Medullary; Carcinoma, Papillary; Humans; Indoles; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Thyroid Neoplasms | 2010 |
Hematologic toxicity in patients treated with sunitinib for advanced thyroid cancer.
Topics: Adult; Aged; Carcinoma, Medullary; Cell Differentiation; Combined Modality Therapy; Enzyme Inhibitors; Female; Hematopoietic System; Humans; Indoles; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Pyrroles; Receptor Protein-Tyrosine Kinases; Sunitinib; Thyroid Neoplasms | 2010 |
Neoadjuvant treatment of unresectable medullary thyroid cancer with sunitinib.
Topics: Antineoplastic Agents; Carcinoma, Medullary; Humans; Indoles; Male; Middle Aged; Neoadjuvant Therapy; Pyrroles; Sunitinib; Thyroid Neoplasms | 2010 |
Identification of soluble candidate biomarkers of therapeutic response to sunitinib in medullary thyroid carcinoma in preclinical models.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Medullary; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Indoles; Interleukin-8; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Pyrroles; RNA Interference; Sunitinib; Tenascin; Thyroid Neoplasms; Transforming Growth Factor beta2; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Response to sunitinib in medullary thyroid cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Medullary; Female; Humans; Indoles; Proto-Oncogene Proteins c-ret; Pyrroles; Sunitinib; Thyroid Neoplasms | 2008 |